ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Tumour Sites: Haematological Malignancies
Clinical Practice Guidelines
Latest ESMO videos
E-Learning
ESMO E-Learning: Mantle Cell Lymphoma
ESMO E-Learning: Marginal Zone B-Cell Lymphoma
ESMO E-Learning: Modern Management of Diffuse Large B-Cell Lymphoma (DLBCL)
ESMO E-Learning: Established and Emerging Therapies for Acute Myeloid Leukaemia
Meeting resources
Resistance to CART therapy
Presenter: Patrizia Porazzi
Session: Adoptive cell therapies in solid tumours
Resources:
Slides
Webcast
Minimal residual disease as a surrogate for early drug development
Presenter: Davide Rossi
Session: Surrogate endpoints in early phase drug development
Resources:
Slides
Webcast
73P - Imatinib induced thyroid dysfunction in BCR::ABL1-positive chronic myeloid leukemia (CML) patients: Sokal score as a predictor
Presenter: Ibrahim Ahmed
Session: Cocktail and Poster Display session
Resources:
Abstract
11P - snRNP200 reactive antibodies isolated from multiple AML patients show promise for targeted therapy
Presenter: Sebastian Baumann
Session: Cocktail and Poster Display session
Resources:
Abstract
12P - KBA1413, an antibody derived from a cured AML patient, recognizes a unique CD43 glycoform shared by AML, MDS and solid cancer cells
Presenter: Vanessa Clerico Mosina
Session: Cocktail and Poster Display session
Resources:
Abstract